Both in Pharmaceuticals
Akebia Therapeutics vs ALX Oncology Holdings
Over the past year AKBA returned −66.1% and ALXO returned −16.9%; their daily moves had a correlation of 0.20.
AKBA −66.1% ALXO −16.9%Growth of $1, one year, split-adjusted
| Metric | AKBA | ALXO |
|---|---|---|
| Price | $0.7177 | $1.31 |
| Market cap | $198.9M | $180.5M |
| Today | +1.32% | −4.74% |
| 1 month | −21.2% | +7.9% |
| 6 months | −50.5% | −32.4% |
| Year to date | −55.4% | +15.5% |
| 1 year | −67.5% | −15.3% |
| Revenue growth (YoY) | −21.4% | — |
| Gross margin | 78.8% | — |
| Net margin | −18.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $106.0M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 71.9% | 92.8% |
| Short % of float | 8.7% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).